pregnancy tirzepatide Semaglutide vs Tirzepatide: Which Works Faster? Tirzepatide and Pregnancy: Safety Facts

Integrating metabolomics and transcriptomics to characterize differential functional capabilities of kidney proximal tubule cell subtypes

More people need treatment for obesity: The rise in obesity rates parallels the rise in GLP-1 prescriptions

the average weight loss with tirzepatide was 17.2 kg, or 16.5% of body weight

Arch Esp Urol 1996

Patients were initially given a 12 mg dose of once-daily oral orforglipron or matching placebo, which was then increased every 4 weeks until the randomized maintenance dose of 36 mg or maximum tolerated dose was reached

This model works well when payer reimbursement exceeds acquisition cost